title: Synthesis and antitumor activity of CBI-bearing ester and carbamate prodrugs of CC-1065 analogue.
abstract: Prodrugs of a CBI-bearing CC-1065 analogue were synthesized. Antitumor activity of the compounds was evaluated against tumor cells in vitro and in mouse tumor models. Compounds 1 and 7, bearing methylpiperazine and DHA moieties, respectively, showed significant antitumor activity in both the L1210 leukemia and Lewis lung carcinoma mouse tumor models. For the carbamate prodrugs 1-4 and 6, there is a good correlation between the drug's potency both in vitro and in animal tumor models; however, there is no correlation between the prodrug's antitumor activity and the type of bonds linking the free drug. There are no significant differences between the antitumor activities of those that can or cannot be protonated at physiological pH. Compounds 6 and 7, each bearing a DHA moiety, did not show significantly improved antitumor activity compared to other prodrugs bearing DHA moieties, suggesting that DHA may not be used universally to significantly improve a drug's antitumor efficacy.
authors.affiliation: Institute of New Drug Research, Jinan University College of Pharmacy, Guangzhou 510632, China. yqwangphd@yahoo.com
authors.forename: Yuqiang
authors.initials: Y
authors.lastname: Wang
authors.forename: Lianfa
authors.initials: L
authors.lastname: Li
authors.forename: Zhiming
authors.initials: Z
authors.lastname: Tian
authors.forename: Wei
authors.initials: W
authors.lastname: Jiang
authors.forename: James W
authors.initials: JW
authors.lastname: Larrick
mesh_terms: D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000138:chemical synthesis* / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D002219:Carbamates; D018827:Carcinoma, Lewis Lung / Q000188:drug therapy / Q000473:pathology; D045744:Cell Line, Tumor; D003521:Cyclopropanes; D004354:Drug Screening Assays, Antitumor; D000080890:Duocarmycins; D004952:Esters; D006863:Hydrogen-Ion Concentration; D007211:Indoles / Q000138:chemical synthesis* / Q000494:pharmacology; D007938:Leukemia / Q000188:drug therapy / Q000473:pathology; D051379:Mice; D011355:Prodrugs / Q000737:chemistry* / Q000494:pharmacology; D013329:Structure-Activity Relationship
chemical_list: C506823:1,2,9,9a-tetrahydrocyclopropa(1,2-c)benz(1,2-e)indol-4-one; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D002219:Carbamates; D003521:Cyclopropanes; D000080890:Duocarmycins; D004952:Esters; D007211:Indoles; D011355:Prodrugs; C018782:CC 1065